About Fluorogenics
Fluorogenics is a company based in Salisbury (United Kingdom) founded in 2011 was acquired by New England Biolabs in May 2021. The company has 8 employees as of December 31, 2020. Fluorogenics operates in a competitive market with competitors including ArcherDX, Qiagen, Devyser, Third Wave Technologies and DxTerity, among others.
- Headquarter Salisbury, United Kingdom
- Employees 8 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name New England Biolabs Lyophilization Sciences Ltd.
- Date of Incorporation 26 Aug, 2011
- Jurisdiction HITCHIN, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$56.11 K (USD), Grant
Sep 30, 2016
-
Investors
European Union
& 2 more
-
Employee Count
8
as on Dec 31, 2020
-
Acquired by
New England Biolabs
(May 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Fluorogenics
Investors in Fluorogenics
Fluorogenics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, New England Biolabs and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Molecular biology reagents company
|
Locked | Locked | Locked |
Investor details for Fluorogenics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fluorogenics
Investment portfolio details for Fluorogenics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fluorogenics
Detailed financials for Fluorogenics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fluorogenics Comparisons
Peer comparison for Fluorogenics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fluorogenics
Fluorogenics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Qiagen, Devyser, Third Wave Technologies and DxTerity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
|
| Locked | Locked | Locked |
Molecular diagnostic devices and reagents are developed and marketed.
|
|
| Locked | Locked | Locked |
Provider of a direct-to-consumer, non-clinical genetic tests
|
|
| Locked | Locked | Locked |
Molecular diagnostic kits for infectious diseases are developed and manufactured.
|
Detailed competitors of Fluorogenics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fluorogenics
Complete news archive for Fluorogenics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fluorogenics
Fluorogenics was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Fluorogenics is headquartered in Salisbury, United Kingdom. It is registered at Salisbury, Wiltshire, United Kingdom.
As of Dec 31, 2020, the latest employee count at Fluorogenics is 8.
Fluorogenics was founded in 2011 and is based in Salisbury, United Kingdom. Operations focus on molecular biology products, particularly ambient-stored nucleic acid amplification reagents stabilized through lyophilization for up to three years at 15-30C. The portfolio encompasses master mixes, kit reagents, vial products for 96- and 384-well plates, cirrus strips, and taqtonix, supporting PCR applications in research and diagnostics.
Fluorogenics has 3 investors. Key investors include European Union, New England Biolabs, and EIC Fund.